Candesartan cilexetil 16 MG TB 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FU411
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,789
Award facts
- Contract value 100% obligated
- $18,789.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) valued at $18,789.23. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, represents a pharmaceutical supply fulfillment under AmerisourceBergen's existing federal contract vehicles. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Candesartan Cilexetil, an antihypertensive medication, represents one of many therapeutic categories AmerisourceBergen provides through its federal contract portfolio, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26FU411?
SPE2DR26FU411 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FU411 worth?
The government has obligated $18,789 on SPE2DR26FU411.
Is contract SPE2DR26FU411 an order under another contract?
Yes. SPE2DR26FU411 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU411 competed?
The extent of competition for SPE2DR26FU411 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award